SBC Medical Group Holdings, incorporated in Delaware in 2023 and headquartered in Tokyo, Japan, provides management services to cosmetic treatment centers primarily in Japan, with additional locations in Vietnam and California.
| Revenue (TTM) | $173.61M |
| Gross Profit (TTM) | $127.28M |
| EBITDA | $70.17M |
| Operating Margin | 32.50% |
| Return on Equity | 22.30% |
| Return on Assets | 13.10% |
| Revenue/Share (TTM) | $1.69 |
| Book Value | $2.42 |
| Price-to-Book | 1.85 |
| Price-to-Sales (TTM) | 2.56 |
| EV/Revenue | 1.993 |
| EV/EBITDA | 4.08 |
| Quarterly Earnings Growth (YoY) | 117.50% |
| Quarterly Revenue Growth (YoY) | -10.90% |
| Shares Outstanding | $102.58M |
| Float | $91.42M |
| % Insiders | 85.22% |
| % Institutions | 1.30% |